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Role of enhanced ceramide generation in DNA damage and cell
death in chemical hypoxic injury to LLC-PK1 cells.
Background. Ceramide has been implicated to be a second
messenger in the cell signaling pathway involved in cell growth,
proliferation, and apoptotic cell death. However, there is little
information of a role of ceramide in DNA damage and cell death
in hypoxic injury known to induce necrotic cell death.
Methods. Ceramide generation was measured in LLC-PK1 cells
exposed to chemical hypoxia with a mitochondrial electron trans-
port inhibitor, antimycin A and glucose deprivation. The effect of
inhibition of ceramide generation on chemical hypoxia-induced
DNA damage and cell death and the effect of exogenous cer-
amide on cellular injury were also determined.
Results. Chemical hypoxia resulted in a rapid increase in
ceramide production prior to any evidence of DNA damage and
cell death in LLC-PK1 cells. The inhibitor of ceramide synthase,
fumonisin B1, provided a marked protection against chemical
hypoxia-induced DNA strand breaks, DNA fragmentation and
cell death. Fumonisin B1 did not affect adenosine triphosphate
(ATP) depletion induced by antimycin A, suggesting that fumo-
nisin B1 does not alter cellular uptake of antimycin A. We
confirmed the ability of ceramide synthase inhibitor, fumonisin
B1, to suppress chemical hypoxia-induced ceramide generation.
Exposure of LLC-PK1 cells to synthetic ceramide, C2- and
C6-ceramide, but not C2-dihydroceramide, the structural analog
of C2-ceramide, resulted in DNA strand breaks, DNA fragmen-
tation and cell death in a dose- and time-dependent manner
similar to the effect of chemical hypoxia.
Conclusions. Our data indicate that ceramide is a key modula-
tor for DNA damage and cell death in chemical hypoxia to renal
tubular epithelial cells.
Membrane lipids are composed primarily of phospholip-
ids, sphingolipids, and cholesterol. Although the major role
of membrane lipids has been thought to be a structural
barrier for cell permeability as well as a matrix for the
association of membrane proteins, it is now recognized that
the products formed by hydrolysis of membrane phospho-
lipids can serve as key molecules in the cell signaling
pathway [1–3]. Ceramide, a metabolite of sphingolipids,
can be generated by condensation of sphinganine or sphin-
gosine and fatty acyl-CoA through the enzyme, ceramide
synthase (sphingosine and sphinganine N-acyltransferase)
or by degradation of sphingomyelin into phosphorylcholine
and ceramide by the action of sphingomyelinases. Recently,
ceramide has been implicated to play an important role in
cell signaling pathway involved in growth arrest, differen-
tiation, and apoptotic cell death [1–3].
Although DNA fragmentation (as a result of endonucle-
ase activation) is considered a biochemical hallmark of
apoptotic mode of cell death [4], several recent in vivo
studies have demonstrated DNA fragmentation in isch-
emia/reperfusion injury [5–9] classically considered to re-
sult in a necrotic form of cell death. In addition, in our
recent studies we have demonstrated that endonuclease
activation is an early event responsible for DNA damage
and cell death in hypoxia/reoxygenation injury to rat renal
proximal tubules [10] and chemical hypoxia to cultured
renal tubular epithelial cells (LLC-PK1 cells) [11, 12].
However, the precise mechanism(s) of endonuclease acti-
vation that results in DNA fragmentation and cell death in
chemical hypoxic injury to LLC-PK1 cells remains to be
elucidated.
The role of ceramide has been studied in apoptotic form
of cell death [reviewed in 1–3]. However, there is little
information of a role of ceramide in hypoxic injury, which
is known to induce necrotic cell death [10–14]. Recent in
vivo studies of ischemic injury have shown an increase in
ceramide level in rat brain subjected to focal ischemia [15]
and ischemic mouse kidney during a brief period of reper-
fusion [16]. The latter study has also shown that subjecting
isolated mouse proximal tubules to hypoxia resulted in an
increase in ceramide level and that addition of exogenous
ceramide to cultured human proximal tubule cells (HK-2
cells) worsened cell death induced by challenge of antimy-
cin and calcium ionophore [16]. However, there is no
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information on the cause-effect relationship between an
alteration of intracellular ceramide and DNA damage and
cell death induced by hypoxic injury in any tissue. The
present study was undertaken to examine a role of cer-
amide as one of the cellular mechanisms leading to DNA
damage and cell death in hypoxic injury to LLC-PK1 cells.
Our data provide the first evidence that chemical hypoxia
results in an increase in ceramide generation through
activation of ceramide synthase, and that ceramide is a key
modulator of DNA damage and cell death in hypoxic injury
to renal epithelial tubule cells.
METHODS
Cell culture
LLC-PK1 cells obtained from the American Type Cul-
ture Collection (Rockville, MD, USA) were cultured as in
our previous studies [11, 12]. Cultures were maintained in
a humidified incubator gassed with 5% CO2- 95% air at
37°C and fed at intervals of 48 to 72 hours. Cells were used
two days after confluency.
Experimental protocol
Chemical hypoxia was induced using a combination of a
mitochondrial electron transport inhibitor, antimycin A,
and glucose deprivation (glucose-free DMEM) as previ-
ously described [11–13]. In brief, LLC-PK1 cells were
rinsed with DMEM without serum, glutamine, pyruvate,
non essential amino acids or glucose, containing 3.7 g/liter
NaHCO3 (Life Technologies, Gaitherburg, MD, USA) and
20 mM Hepes at pH 7.4, and then the cells were incubated
in the same glucose-free DMEM either with or without
antimycin A (10 mM) for different time intervals as indi-
cated. The dose of antimycin A used in the study was based
on our previous studies [11, 12]. To determine the effect of
the inhibitor of ceramide synthase, fumonisin B1, which
blocks ceramide synthase resulting in a decrease in intra-
cellular ceramide level [17, 18], on chemical hypoxic injury,
cells were washed with glucose-free DMEM, preincubated
with fumonisin B1 (50 mM) in glucose-free DMEM for one
hour, and then exposed to antimycin A. The chosen dose of
fumonisin B1 was based on previously described informa-
tion [18]. To determine the effect of exogenous ceramide
on DNA damage and cell death, cells were washed with
glucose-free DMEM and incubated with various concen-





ceramide (N-hexanoyl-D-erythro-sphingosine), and fumoni-
sin B1 were purchased from Calbiochem (La Jolla, CA,
USA) and stock solutions were prepared in 100% ethanol,
except that fumonisin B1 was dissolved in glucose-free
DMEM.
Lipid studies
The lipids were extracted by the method of Bligh and
Dyer [19]. Ceramide was quantitated by the diacylglycerol
(DG) kinase assay as previously described [20]. In brief, the
dried extracted lipids under N2 were dissolved in 20 ml of
7.5% n-octyl-b-glucopyranoside, 25 mM dioleoylphosphati-
dylglycerol, 1 mM diethylenetriaminepentaacetic acid (DE-
TAPAC), pH 7.0. Then the following solutions were added
in order: 50 ml of reaction buffer containing 100 mM
imidazole HCl, pH 6.6, 100 mM NaCl, 25 mM MgCl2, and 2
mM EGTA, pH 6.6, 2 ml of 100 mM dithiothreitol in 1 mM
DETAPAC, pH 7.0, 10 ml of DG kinase (5 mg/10 ml) from
the E. coli strain N4830/pJW10 (Calbiochem) diluted in 100
mM imidazole-HCl and 1 mM DETAPAC, pH 6.6, and 8 ml
of water. The reaction was initiated by the addition of 10 ml
of 10 mM [g-32P]ATP (4.5 mCi per sample) in 20 mM
imidazole, pH 6.6, 1 mM DETAPAC, and incubated at 25°C
for 45 minutes. The reaction was stopped by addition of 0.7
ml of 1% (wt/vol) perchloric acid. The lipids were extracted
with 3 ml of methanol/chloroform (2/1, vol/vol), 1 ml of
chloroform and 1 ml of 1% perchloric acid. The lower
chloroform phase was washed with 2 ml of 1% perchloric
acid/methanol (7/1, vol/vol) and then used for measure-
ment of ceramide. The standard ceramide type III (from
bovine brain; Sigma Chemical Co., St. Louis, MO, USA)
was also treated in the same manner. Ceramide 1-phos-
phate was resolved by thin-layer chromatography (TLC) on
silica gel 60 plates (Whatman, Hillsboro, OR, USA) that
was preactivated by acetone using a solvent system of
chloroform/acetone/methanol/acetic acid/water (10/4/3/2/1,
vol/vol/vol/vol/vol). The TLC plate was dried and autora-
diographed overnight. The band corresponding to cer-
amide 1-phosphate was scraped and incorporation of 32P
into ceramide 1-phosphate was quantitated by Cerenkov
scintillation counting. The level of ceramide was deter-
mined by comparison with a standard curve generated
concomitantly of known amounts of ceramide (Ceramide
type III). Data are expressed as pmoles ceramide/nmole of
total lipid phosphate determined by the method of Ames
and Dubin [21].
Determination of DNA strand breaks
The residual double strand DNA was measured by the
alkaline unwinding assay and determination of ethidium
bromide fluorescence utilized in our previous studies [10–
12, 22]. Ethidium bromide fluorescence was measured at
520 nm excitation and 590 nm emission using a fluores-
cence spectrophotometer. Under the conditions employed,
ethidium bromide binds preferentially to double strand
DNA. The percent of residual double strand DNA (D) was
determined by the equation: %D 5 100 3 [F(P) 2
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F(B)]/[F(T) 2 F(B)], where F(P) is the sample fluores-
cence, F(T) is the total fluorescence prior to alkaline
treatment, and F(B) is the background fluorescence that
was obtained from sonicated, alkaline treated DNA, a
condition under which the DNA is completely unwound
and represents the fluorescence due to all components
other than double strand DNA.
DNA fragmentation analysis
Cells were pelleted by centrifugation and resuspended in
a lysis buffer (0.5% vol/vol Triton X-100, 25 mM EDTA and
10 mM Tris-HCl, pH 8.0) for 30 minutes at 0°C. The
samples were then centrifuged at 14,000 g for 30 minutes to
separate chromatin pellet from fragmented DNA as previ-
ously described [10–12, 22]. The fragmented DNA in the
supernatant was extracted with an equal volume of phenol/
chloroform/isoamyl alcohol (49/49.5/1), precipitated with
0.1 vol of 10 M ammonium acetate and 2.5 vol of absolute
ethanol. The same amount of nucleic acid determined by
UV absorbance was incubated with 3 ml of RNase A (10
mg/ml) at 37°C for four hours, and then subjected to
electrophoresis on a 1.0% agarose gel containing ethidium
bromide.
Determination of cell injury
Cell viability was determined using trypan blue exclusion
as previously described [11, 12, 22].
Measurement of cellular adenosine triphosphate
Cellular ATP content was measured by luciferin/lucif-
erase assay as previously described [11, 13].
Statistics
Results are means 6 SE. Statistical significance was
determined by unpaired Student’s t-test. A P value less than
0.05 was considered statistically significant.
RESULTS
Effect of chemical hypoxia on ceramide generation
To examine whether chemical hypoxia enhances intra-
cellular ceramide production, we determined the time
course of the effect of chemical hypoxia on ceramide
generation in LLC-PK1 cells. As shown in Figure 1, expo-
sure of LLC-PK1 cells to antimycin A (10 mM) resulted in a
rapid increase in ceramide generation. The intracellular
ceramide level was increased from 10.6 6 1.5 to 23.6 6 4.4
pmol/nmol phosphate (N 5 7, P , 0.02) within one minute
(earliest time point examined) after exposure of cells to
chemical hypoxia, and thereafter continuously increased up
to 60 minutes (43.7 6 7.7 pmol/nmol phosphate, N 5 7, P ,
0.002). The value for ceramide in control cells was slightly
increased from 10.6 6 1.5 pmol/nmol phosphate at 0 time
point to 15.2 6 1.4 pmol/nmol phosphate (N 5 7) at 60
minutes of incubation. This may be due to the effect of
serum withdrawal [23]. However, as compared to the
control value at 60 minutes of incubation, chemical hypoxia
resulted in significant increase in ceramide level at the
same time point (P , 0.002). Therefore, our data showed
that chemical hypoxia indeed resulted in significant in-
crease in intracellular ceramide production in LLC-PK1
cells. In our previous study we showed that antimycin A (10
mM) caused significant DNA strand breaks in LLC-PK1
cells in a time-dependent manner, which started at 30
minutes after exposure of the cells, and under that condi-
tion it caused significant cell death at 60 minutes after
exposure [11]. Taken together, these data indicate that
chemical hypoxia-induced enhanced ceramide generation
occurs very early and prior to any evidence of DNA damage
or cell death (see below).
Effect of fumonisin B1 on chemical hypoxia-induced
DNA strand breaks
To determine if there was a role for ceramide in chemical
hypoxia-induced DNA damage, we examined the effect of
inhibition of ceramide utilizing an inhibitor of ceramide
synthase, fumonisin B1, on chemical hypoxia-induced DNA
strand breaks. For this study we utilized a 60-minute time
point after exposure of cells to chemical hypoxia [11]. As
shown in Figure 2A, fumonisin B1 (50 mM) was highly
protective against chemical hypoxia-induced DNA strand
breaks (residual double strand DNA, 82 6 1%, compared
to cells treated with antimycin A alone, 49 6 2%; N 5 3,
P , 0.0002). In a separate study, we examined the effect of
Fig. 1. Time course of effect of chemical hypoxia on ceramide generation
in LLC-PK1 cells. Cells were incubated with antimycin A (10 mM) in a
glucose-free DMEM for different time points (0, 1, 5, 30, and 60 min).
Ceramide was measured by the DG kinase assay as described in the
Methods section. Results are means 6 SE, N 5 5 to 7. *P , 0.02, **P ,
0.002, compared to zero time point.
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fumonisin B1 on chemical hypoxia-induced DNA fragmen-
tation (Fig. 2B). Fumonisin B1 also provided a marked
protection against DNA fragmentation in LLC-PK1 cells
subjected to chemical hypoxia. We considered the possibil-
ity that fumonisin B1 could prevent ATP depletion induced
by chemical hypoxia, thereby protecting against DNA dam-
age. To exclude this possibility we measured cellular ATP
in cells exposed to antimycin A (10 mM) for 60 minutes in
the absence or presence of fumonisin B1. Under this
condition, cellular ATP declined from 31.0 6 0.05 to 0.5 6
0.02 nmol/mg protein in cells treated with antimycin A
alone (N 5 3). There was no difference in the cellular ATP
level between cells exposed to antimycin A alone and those
pretreated with 50 mM fumonisin B1 (0.6 6 0.07 nmol/mg
protein, N 5 3), suggesting that the inhibitor does not alter
the uptake of antimycin A by the cells. Taken together,
these data suggest that the inhibitor of ceramide synthase is
highly protective against chemical hypoxia-induced DNA
damage in LLC-PK1 cells.
Effect of fumonisin B1 on chemical hypoxia-induced cell
death
We next examined the effect of the inhibitor of ceramide
synthase, fumonisin B1, on chemical hypoxia-induced cell
death. In our previous study [11], we demonstrated that
chemical hypoxia with antimycin A and glucose deprivation
results in a significant cell death in LLC-PK1 cells at 120
and 180 minutes after exposure to antimycin A. Thus, we
utilized a 120-minute time point after exposure of cells to
chemical hypoxia. As shown in Figure 3, fumonisin B1
provided a partial but significant protection against chem-
ical hypoxia-induced cell death as measured by trypan blue
exclusion (control, 8 6 1%, antimycin A alone, 43 6 1% vs.
antimycin A plus fumonisin B1, 18 6 1%; N 5 5, P ,
Fig. 2. (A) Effect of an inhibitor of ceramide synthase, fumonisin B1, on
chemical hypoxia-induced DNA strand breaks in LLC-PK1 cells. Results
are means 6 SE, N 5 3. *P , 0.0002, compared to cells exposed to
antimycin A alone. Cells were preincubated with fumonisin B1 (50 mM) in
glucose-free DMEM prior to induction of chemical hypoxia with antimy-
cin A (10 mM) for 60 minutes. DNA strand breaks were determined by the
alkaline unwinding assay. (B) Effect of an inhibitor of ceramide synthase,
fumonisin B1, on chemical hypoxia-induced DNA fragmentation in LLC-
PK1 cells. Cells were preincubated with fumonisin B1 (50 mM) for 60
minutes, and then exposed to antimycin A (10 mM) for 60 minutes. Lane
1, control; lane 2, antimycin A alone; lane 3, antimycin A plus fumonisin
B1. Results are the representative of four experiments.
Fig. 3. Effect of an inhibitor of ceramide synthase, fumonisin B1, on
chemical hypoxia-induced cell death in LLC-PK1 cells. Results are
means 6 SE, N 5 5, P , 0.0001, compared to cells exposed to antimycin
A alone. Cells were preincubated with fumonisin B1 (50 mM) for 60
minutes prior to induction of chemical hypoxia with antimycin A (10 mM)
for 120 minutes. The cell viability was measured by trypan blue exclusion.
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0.0001). We confirmed that fumonisin B1 did not alter the
uptake of trypan blue dye by the cells (data not shown).
Taken together, these data suggest that the inhibitor of
ceramide synthase is protective against chemical hypoxia-
induced cell death in LLC-PK1 cells.
Effect of fumonisin B1 on chemical hypoxia-induced
ceramide generation
In separate studies, we examined the ability of fumonisin
B1 to suppress chemical hypoxia-induced ceramide gener-
ation in LLC-PK1 cells. As shown in Figure 4, fumonisin B1
prevented chemical hypoxia-induced ceramide generation.
Effect of exogenous ceramide on DNA damage
To determine whether ceramide by itself induces DNA
damage and cell death, we examined the effect of exoge-
nous ceramide on DNA damage in LLC-PK1 cells. As
shown in Figure 5, C2-ceramide and C6-ceramide induced
DNA strand breaks in a time- and dose-dependent manner.
However, C2-dihydroceramide, the structural analog of
C2-ceramide, did not induce DNA strand breaks (residual
double strand DNA; control, 90 6 1%, 10 mM C2-dihydro-
ceramide, 89 6 1%, N 5 3). Similarly, C2-ceramide and
C6-ceramide resulted in DNA fragmentation in LLC-PK1
cells (Fig. 5C).
Effect of exogenous ceramide on cell death
We finally examined the effect of exogenous ceramide on
cell death in LLC-PK1 cells. As shown in Figure 6A,
exposure of LLC-PK1 cells to C2-ceramide and C6-cer-
amide, but not C2-dihydroceramide, resulted in significant
cell death in a time-dependent manner (cell death at 120
min: C2-ceramide, 38 6 4%, P , 0.0001; C6-ceramide,
40 6 1%, P , 0.0001; and C2-dihydroceramide, 14 6 2%,
NS; compared to control cells, 12 6 2%, N 5 3 to 4). The
administration of C2-ceramide and C6-ceramide also
caused cell death in a dose-dependent manner (Fig. 6B).
The synthetic ceramide used in the study did not affect the
cellular uptake of trypan blue dye (data not shown). These
data suggest that ceramide is capable of inducing DNA
damage and cell death in LLC-PK1 cells and that the effect
of exogenous ceramide on DNA damage and cell death
mimics that of chemical hypoxia.
Taken together, our data provide strong evidence that
enhanced generation of ceramide is a key modulator for
DNA damage and cell death in chemical hypoxic injury to
LLC-PK1 cells.
DISCUSSION
Ceramide has a variety of biological functions in a cell
signaling pathway through its targeted proteins and, thus,
functions as an intracellular mediator of cytotoxicity [1–3].
Exogenous ceramide or other analogs can induce apoptosis
in hematopoietic and nonhematopoietic cells [24–28]. In
addition, an increased ceramide level has been demon-
strated in the apoptotic mode of cell death induced by a
variety of stimuli such as tumor necrosis factor-a [29, 30],
irradiation [31–33], Fas [34, 35], anti-immunoglobulin M
[31], cytokines [29, 36], growth factors [37], serum depriva-
tion [23], corticosteroids [31], chemotherapeutic agents [25,
38], complement activation [39], oxidants [25, 40], or heat
shock [40]. Recent studies have demonstrated that the
lymphoid cells deficient in ceramide production [32] and
breast carcinoma cells with low response of ceramide
production [30] are resistant to apoptosis induced by
irradiation or tumor necrosis factor-a, indicating that the
level of ceramide production in response to stimuli is a
determinant factor of cytotoxicity. These lines of evidence
suggest that ceramide functions as a key molecule for the
cell signaling pathway involved in apoptosis.
A role of ceramide has been better characterized in the
apoptotic form of cell death; however, there is little infor-
mation of a role of ceramide in hypoxic injury known to
induce the necrotic form of cell death [10–14]. Ischemia in
vivo results in enhanced ceramide levels in the rat cerebral
cortex [15], whereas it results in a decrease in ceramide in
the mouse kidney followed by an increase after a brief
period of reperfusion [16]. In the present study, we have
shown that chemical hypoxia resulted in a rapid increase in
Fig. 4. Effect of an inhibitor of ceramide synthase, fumonisin B1, on
chemical hypoxia-induced increase in ceramide production in LLC-PK1
cells. Cells were preincubated with fumonisin B1 (50 mM) for 60 minutes
prior to addition of antimycin A (10 mM) for 60 minutes. Results are
means 6 SE, N 5 3 to 5. *P , 0.002, compared to cells exposed to
antimycin A alone.
Ueda et al: Ceramide in hypoxic injury 403
ceramide generation in LLC-PK1 cells prior to any evi-
dence of DNA damage and cell death. The similar increase
in ceramide level has been reported in isolated proximal
tubules subjected to hypoxia, whereas a glycerol challenge
did not cause a significant alteration in ceramide level [16],
suggesting that alteration of ceramide levels varies with
stimuli even in the same cells.
One striking aspect of our data is the rapidity with which
ceramide generation occurs (within one minute) after
exposure of cells to chemical hypoxia. The rapidity of
ceramide generation in response to stimuli ranges from
seconds to hours [2]. In addition, in vitro studies have
shown that de novo synthesis of ceramide by ceramide
synthase in mouse brain microsomes occurs very rapidly
(within one minute) and reaches the maximum level at 20
to 30 minutes [41]. Thus, our data showing a rapid increase
in ceramide generation in response to chemical hypoxia are
similar to those described in previous studies [33, 35, 36, 40].
The data in our studies have shown that the specific
inhibitor of ceramide synthase, fumonisin B1, provided a
marked protection against chemical hypoxia-induced DNA
strand breaks, DNA fragmentation and cell death. Fumo-
nisin B1 has been demonstrated to inhibit ceramide syn-
thase, resulting in a decrease in ceramide levels in mam-
malian cells [17, 18]. In fact, our data confirmed the ability
of fumonisin B1 to suppress ceramide generation induced
by chemical hypoxia in LLC-PK1 cells. These data suggest
that the inhibition of intracellular ceramide production
confers the resistance to chemical hypoxia-induced DNA
damage and cell death in renal tubular epithelial cells, and
that the intracellular ceramide level is a determinant of
cytotoxicity in hypoxic injury.
Intracellular ceramide can be generated by condensation
of sphingosine or sphinganine and fatty acyl-CoA by cer-
amide synthase or by hydrolysis of sphingomyelin by sphin-
gomyelinase [1–3]. However, the study by Zager et al
showed that there was no significant change in sphingomy-
elin content in hypoxic tubules [16]. Although we cannot
exclude the contribution of hydrolysis of sphingomyelin by
sphingomyelinases to ceramide generation, our observa-
tions with a specific inhibitor of ceramide synthase, fumo-
nisin B1, coupled with these data, imply that ceramide
synthase can be activated by hypoxic stimuli and that the
ceramide synthase-dependent pathway is a major target for
stress signaling in hypoxic injury.
There is little information of a role of ceramide synthase
in tissue injury. A recent study [38] has shown that dauno-
rubicin, a chemotherapeutic agent, induces apoptosis
through activation of ceramide synthase but not sphingo-
myelinase. One of the major sites of ceramide synthase is
Fig. 5. (A) Time course of effect of exogenous ceramide on DNA strand
breaks in LLC-PK1 cells. Results are means 6 SE, N 5 3. *P , 0.02,
compared to zero time point. Cells were incubated with 10 mM C2-
ceramide (E) or C6-ceramide () for up to one hour. (B) Effect of dose
dependency of exogenous ceramide on DNA strand breaks in LLC-PK1
cells. Results are means 6 SE, N 5 3. Cells were incubated with various
concentrations of C2-ceramide (M) or C6-ceramide (f) (0 to 20 mM) for
one hour. (C) Effect of exogenous ceramide on DNA fragmentation in
LLC-PK1 cells. Lane 1, control; lane 2, C2-ceramide 10 mM; lane 3,
C6-ceramide 10 mM. Results are representative of four experiments.
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microsomal membranes [41–43]; however, the enzyme also
exists at membranes of mitochondria, lysosomes or endo-
plasmic reticulum [41, 44–46]. Because no successful puri-
fication of ceramide synthase has been reported thus far,
little is known about the enzyme.
In separate studies, we have shown that exogenous
C2-ceramide and C6-ceramide (but not C2-dihydroceram-
ide, a structural analog of C2-ceramide) induced DNA
strand breaks, DNA fragmentation and cell death in a
dose- and time-dependent manner. The lack of ability for
C2-dihydroceramide to induce cellular injury has also been
reported in other studies [47]. Dihydroceramide differs
structurally from ceramide only in the absence of the
double bond between carbons 4 and 5 of the sphingoid
backbone. Both ceramide and dihydroceramide have simi-
lar kinetics of uptake and minimal metabolism [47]. Thus,
the ability of exogenous C2-ceramide and C6-ceramide to
induce DNA damage and cell death is a specific phenom-
enon and mimics the effect of chemical hypoxia in LLC-
PK1 cells. These observations, coupled with the finding that
low ceramide level acquires resistance to hypoxic injury,
strongly suggest the involvement of ceramide-dependent
cell signaling pathway for DNA damage and cell death in
hypoxic injury. A number of in vitro studies have demon-
strated that exogenous ceramide can induce apoptosis in a
variety of cells [24–28] as well as cause necrosis in hepato-
cytes [48]. The recent in vitro study has shown that the
exogenous C2-ceramide to HK-2 cells, an immortalized
proximal tubular cell line from human kidney, resulted in
necrotic cell death without DNA fragmentation [49], indi-
cating that the cellular response to exogenous ceramide
vary with cell types. Nonetheless, our data provide strong
evidence that enhanced generation of ceramide induced by
chemical hypoxia is a potential modulator for DNA dam-
age and cell death in chemical hypoxic injury to renal
tubular epithelial cells.
In summary, the present study demonstrates that chem-
ical hypoxia results in a rapid increase in ceramide produc-
tion through ceramide synthase activation prior to any
evidence of DNA damage and cell death in LLC-PK1 cells.
Our data also suggest that the inhibition of ceramide
production by chemical hypoxia prevents DNA damage and
cell death, and that the effect of exogenous ceramide
mimics the cellular injury induced by chemical hypoxia.
Taken together, our data provide strong evidence that
ceramide is a key modulator of DNA damage and cell
death in hypoxic injury to renal tubular epithelial cells.
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